Rani Palaniswamy, Krishnan Sreeram, Rani Cathrine Chellappa
Department of Biotechnology, PSG College of Technology, Coimbatore, India.
Front Neurol. 2017 Jul 14;8:328. doi: 10.3389/fneur.2017.00328. eCollection 2017.
Many factors are involved in Alzheimer's disease (AD) pathology including tau phosphorylation, amyloid β protein (Aβ) accumulation, lipid dysregulation, oxidative stress, and inflammation. The markers of these pathological processes in cerebral spinal fluid are used currently for AD diagnosis. However, peripheral biomarkers are the need of the hour for large population screening for AD. The main objective of the present study is to evaluate the peripheral levels of redox markers, lipid peroxidation (LPO) indicators, and pathological markers in AD patients. Blood was collected from AD patients ( = 45), controls ( = 45), and analyzed for pathological markers of AD including Aβ42 and tau, LPO, and redox indicators. Plasma Aβ42 was significantly ( < 0.001) elevated while total tau was decreased in AD compared to controls. Hydroxynonenal (HNE) and malondialdehyde (MDA) were higher ( < 0.001) in AD patients pointing the enhanced LPO in AD pathology. Receiver operating characteristic curve (ROC) analysis indicated that HNE is a better indicator of LPO compared to MDA. Plasma glutathione (GSH) level was significantly ( < 0.001) low while oxidized glutathione (GSSG) level was higher ( < 0.001) in AD patients with corresponding decrease in GSH/GSSG ratio ( < 0.001). ROC analysis indicated that GSH/GSSG ratio can be used as reliable indicator for redox imbalance in AD with a cutoff value of <8.73 (sensitivity 91.1%, specificity 97.8%). Correlation analysis revealed a positive correlation for both HNE and MDA with Aβ42 and a negative correlation with total tau. Negative correlation was observed between GSH/GSSG ratio and LPO markers. While oxidative stress has been implicated in pathology of various neurodegenerative disorders, the present study pinpoints the direct link between LPO and Aβ production in plasma of AD patients. Normally, at low amyloid concentration in body fluids, this peptide shown to function as a strong metal chelating antioxidant. However, when the Aβ production enhanced as in AD, through gain of functional transformation, Aβ evolves into prooxidant, thereby enhancing oxidative stress and LPO. Altered redox status with enhanced LPO observed in AD blood could contribute to the oxidation and -glutathionylation proteins, which has to be addressed in future studies.
阿尔茨海默病(AD)的病理过程涉及多种因素,包括tau蛋白磷酸化、淀粉样β蛋白(Aβ)聚集、脂质代谢失调、氧化应激和炎症。目前,脑脊液中这些病理过程的标志物被用于AD的诊断。然而,外周生物标志物是目前对大量人群进行AD筛查所急需的。本研究的主要目的是评估AD患者外周氧化还原标志物、脂质过氧化(LPO)指标和病理标志物的水平。收集了45例AD患者和45例对照者的血液,并分析了AD的病理标志物,包括Aβ42和tau、LPO以及氧化还原指标。与对照组相比,AD患者血浆Aβ42显著升高(<0.001),而总tau降低。AD患者的羟基壬烯醛(HNE)和丙二醛(MDA)水平更高(<0.001),表明AD病理过程中LPO增强。受试者工作特征曲线(ROC)分析表明,与MDA相比,HNE是LPO更好的指标。AD患者血浆谷胱甘肽(GSH)水平显著降低(<0.001),而氧化型谷胱甘肽(GSSG)水平升高(<0.001),GSH/GSSG比值相应降低(<0.001)。ROC分析表明,GSH/GSSG比值可作为AD氧化还原失衡的可靠指标,临界值<8.73(敏感性91.1%,特异性97.8%)。相关性分析显示,HNE和MDA与Aβ42均呈正相关,与总tau呈负相关。GSH/GSSG比值与LPO标志物呈负相关。虽然氧化应激与各种神经退行性疾病的病理过程有关,但本研究指出了AD患者血浆中LPO与Aβ产生之间的直接联系。正常情况下,在体液中淀粉样蛋白浓度较低时,这种肽表现为一种强大的金属螯合抗氧化剂。然而,当Aβ的产生如在AD中那样通过功能转变增强时,Aβ会演变成促氧化剂,从而增强氧化应激和LPO。在AD血液中观察到的LPO增强导致的氧化还原状态改变可能会导致蛋白质的氧化和谷胱甘肽化,这在未来的研究中必须加以解决。